"LUX Lung 2 Phase II Single Arm BIBW 2992 Afatinib in NSCLC With EGFR Activating Mutations"

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

August 31, 2015

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

BIBW 2992

This is an open label study. Patients are treated with BIBW 2992 until disease progression or undue AEs

Trial Locations (30)

Unknown

1200.22.28 Boehringer Ingelheim Investigational Site, Bakersfield

1200.22.32 Boehringer Ingelheim Investigational Site, Beverly Hills

1200.22.4 Boehringer Ingelheim Investigational Site, Mission Hills

1200.22.16 Boehringer Ingelheim Investigational Site, Orange

1200.22.19 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1200.22.29 Boehringer Ingelheim Investigational Site, North Miami Beach

1200.22.10 Boehringer Ingelheim Investigational Site, Atlanta

1200.22.18 Boehringer Ingelheim Investigational Site, Chicago

1200.22.3 Boehringer Ingelheim Investigational Site, Bethesda

1200.22.14 Boehringer Ingelheim Investigational Site, Boston

1200.22.24 Boehringer Ingelheim Investigational Site, Flint

1200.22.5 Boehringer Ingelheim Investigational Site, Minneapolis

1200.22.15 Boehringer Ingelheim Investigational Site, New York

1200.22.26 Boehringer Ingelheim Investigational Site, New York

1200.22.1 Boehringer Ingelheim Investigational Site, Rochester

1200.22.27 Boehringer Ingelheim Investigational Site, Syracuse

1200.22.25 Boehringer Ingelheim Investigational Site, Valhalla

1200.22.6 Boehringer Ingelheim Investigational Site, Canton

1200.22.7 Boehringer Ingelheim Investigational Site, Wynnewood

1200.22.22 Boehringer Ingelheim Investigational Site, Mt. Pleasant

1200.22.31 Boehringer Ingelheim Investigational Site, Fairfax

1200.22.40 Boehringer Ingelheim Investigational Site, Renton

1200.22.33 Boehringer Ingelheim Investigational Site, Seattle

1200.22.88604 Taichung Veterans General Hospital, Taichung

1200.22.88605 China Medical University Hospital, Taichung

1200.22.88606 Boehringer Ingelheim Investigational Site, Tainan City

1200.22.88601 National Taiwan University Hospital, Taipei

1200.22.88602 Veterans General Hospital, Taipei

1200.22.88607 Boehringer Ingelheim Investigational Site, Taipei

1200.22.88603 Chang Gung Memorial Hosp-Linkou, Taoyuan District

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00525148 - "LUX Lung 2 Phase II Single Arm BIBW 2992 Afatinib in NSCLC With EGFR Activating Mutations" | Biotech Hunter | Biotech Hunter